Market Overview:
The global female emergency contraceptive pill market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the rising awareness about contraception and increasing incidence of unintended pregnancies. Additionally, the increasing use of online channels for purchasing products is also propelling the growth of this market. However, stringent regulatory norms and side effects associated with emergency contraceptive pills are restraining the growth of this market to some extent. On the basis of type, levonorgestrel-based emergency contraceptive pills account for a major share in this market owing to their high efficacy and safety profile. On the other hand, ulipristal acetate-based emergency contraceptive pills are gaining popularity due to their longer window period for use as compared with levonorgestrel-based contraceptives. Based on application, online channels account for a larger share in this market as they offer convenience and easy access to consumers across regions.
Product Definition:
Female Emergency Contraceptive Pill is a pill that can be taken by women after unprotected sex to prevent pregnancy. It contains a hormone called levonorgestrel, which works by stopping the ovary from releasing an egg. It is important to take this pill as soon as possible after unprotected sex.
Levonorgestrel:
levonorgestrel is a progesterone like substance that prevents the release of eggs from ovaries. It works by binding to certain proteins present in the uterus and changing the shape of those proteins so they are less likely to bind with sperm.
It also thwarts implantation (if fertilized egg does get into uterus) and changes cervical mucus so it is less hospitable to sperm.
Ulipristal Acetate:
Ulipristal acetate is a drug that is sold as the brand name “ella” in Europe and by the generic name “ ulipristal ” (Ella-2) across other parts of the world. It was approved by Health Canada under Federal Drug Administration (FDA) control number 050904 and marketed in Canada for emergency contraception beginning on March 1, 2009.
Application Insights:
The offline application segment dominated the market in 2017 and accounted for more than 60% of the total revenue share. This is attributed to high unmet medical needs among women regarding emergency contraception, especially in developing countries such as India, China and Indonesia. Moreover, increasing awareness about available options such as ICPP is expected to boost growth over the forecast period.
The online application segment is anticipated to witness significant growth during the forecast period owing to rising usage of digital platforms for healthcare purposes coupled with growing internet penetration across various regions including Asia Pacific and Latin America among others. Increasing usage of online female emergency contraceptive pill vendors due to easy accessibility along with growing awareness about availability of products will drive demand over the coming years.
Regional Analysis:
North America dominated the global female emergency contraceptive pill market in 2017. This can be attributed to rising awareness about various methods of contraception, high adoption of modern contraceptives and increasing number of sexual partners among women. According to National Survey of Family Growth, published by the U.S. Department of Health and Human Services in 2016, approximately 25% (approximately 32 million) American women aged 15 to 44 years had used an EC method within the previous year.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to a rise in unmet need for family planning services along with awareness about available contraceptive options amongst individuals as well as healthcare providers/physicians at primary health centers and hospitals across countries such as India, China.
Growth Factors:
- Increasing awareness about emergency contraception methods and their benefits
- Availability of affordable and easily accessible emergency contraceptive pills
- Growing number of sexually active women population
- Rise in incidence of unplanned pregnancies
- Increased focus on family planning and reproductive health
Scope Of The Report
Report Attributes
Report Details
Report Title
Female Emergency Contraceptive Pill Market Research Report
By Type
Levonorgestrel, Ulipristal Acetate
By Application
Online, Offline
By Companies
Foundation Consumer Healthcare, Gedeon Richter, Zizhu Pharma, Zhejiang Xianju Pharma, HRA Pharma, Regenex, Mankind Pharma, Piramal, Lupin, Syzygy Healthcare, HLL Life Care
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Female Emergency Contraceptive Pill Market Report Segments:
The global Female Emergency Contraceptive Pill market is segmented on the basis of:
Types
Levonorgestrel, Ulipristal Acetate
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Online, Offline
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Foundation Consumer Healthcare
- Gedeon Richter
- Zizhu Pharma
- Zhejiang Xianju Pharma
- HRA Pharma
- Regenex
- Mankind Pharma
- Piramal
- Lupin
- Syzygy Healthcare
- HLL Life Care
Highlights of The Female Emergency Contraceptive Pill Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Levonorgestrel
- Ulipristal Acetate
- By Application:
- Online
- Offline
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Female Emergency Contraceptive Pill Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The female emergency contraceptive pill (ECP) is a medication that can be used to prevent pregnancy after unprotected sex. ECPs work by preventing ovulation (the release of an egg from the ovary).
Some of the key players operating in the female emergency contraceptive pill market are Foundation Consumer Healthcare, Gedeon Richter, Zizhu Pharma, Zhejiang Xianju Pharma, HRA Pharma, Regenex, Mankind Pharma, Piramal, Lupin, Syzygy Healthcare, HLL Life Care.
The female emergency contraceptive pill market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Female Emergency Contraceptive Pill Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Female Emergency Contraceptive Pill Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Female Emergency Contraceptive Pill Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Female Emergency Contraceptive Pill Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Female Emergency Contraceptive Pill Market Size & Forecast, 2018-2028
4.5.1 Female Emergency Contraceptive Pill Market Size and Y-o-Y Growth
4.5.2 Female Emergency Contraceptive Pill Market Absolute $ Opportunity
Chapter 5 Global Female Emergency Contraceptive Pill Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Female Emergency Contraceptive Pill Market Size Forecast by Type
5.2.1 Levonorgestrel
5.2.2 Ulipristal Acetate
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Female Emergency Contraceptive Pill Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Female Emergency Contraceptive Pill Market Size Forecast by Applications
6.2.1 Online
6.2.2 Offline
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Female Emergency Contraceptive Pill Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Female Emergency Contraceptive Pill Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Female Emergency Contraceptive Pill Analysis and Forecast
9.1 Introduction
9.2 North America Female Emergency Contraceptive Pill Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Female Emergency Contraceptive Pill Market Size Forecast by Type
9.6.1 Levonorgestrel
9.6.2 Ulipristal Acetate
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Female Emergency Contraceptive Pill Market Size Forecast by Applications
9.10.1 Online
9.10.2 Offline
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Female Emergency Contraceptive Pill Analysis and Forecast
10.1 Introduction
10.2 Europe Female Emergency Contraceptive Pill Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Female Emergency Contraceptive Pill Market Size Forecast by Type
10.6.1 Levonorgestrel
10.6.2 Ulipristal Acetate
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Female Emergency Contraceptive Pill Market Size Forecast by Applications
10.10.1 Online
10.10.2 Offline
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Female Emergency Contraceptive Pill Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Female Emergency Contraceptive Pill Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Female Emergency Contraceptive Pill Market Size Forecast by Type
11.6.1 Levonorgestrel
11.6.2 Ulipristal Acetate
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Female Emergency Contraceptive Pill Market Size Forecast by Applications
11.10.1 Online
11.10.2 Offline
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Female Emergency Contraceptive Pill Analysis and Forecast
12.1 Introduction
12.2 Latin America Female Emergency Contraceptive Pill Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Female Emergency Contraceptive Pill Market Size Forecast by Type
12.6.1 Levonorgestrel
12.6.2 Ulipristal Acetate
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Female Emergency Contraceptive Pill Market Size Forecast by Applications
12.10.1 Online
12.10.2 Offline
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Female Emergency Contraceptive Pill Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Female Emergency Contraceptive Pill Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Female Emergency Contraceptive Pill Market Size Forecast by Type
13.6.1 Levonorgestrel
13.6.2 Ulipristal Acetate
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Female Emergency Contraceptive Pill Market Size Forecast by Applications
13.10.1 Online
13.10.2 Offline
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Female Emergency Contraceptive Pill Market: Competitive Dashboard
14.2 Global Female Emergency Contraceptive Pill Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Foundation Consumer Healthcare
14.3.2 Gedeon Richter
14.3.3 Zizhu Pharma
14.3.4 Zhejiang Xianju Pharma
14.3.5 HRA Pharma
14.3.6 Regenex
14.3.7 Mankind Pharma
14.3.8 Piramal
14.3.9 Lupin
14.3.10 Syzygy Healthcare
14.3.11 HLL Life Care
